Clinical value of monoclonal antibodies and tyrosine kinase inhibitors in the treatment of head and neck squamous cell carcinoma.
about
Clinical value of monoclonal antibodies and tyrosine kinase inhibitors in the treatment of head and neck squamous cell carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical value of monoclonal a ...... neck squamous cell carcinoma.
@en
Clinical value of monoclonal a ...... neck squamous cell carcinoma.
@nl
type
label
Clinical value of monoclonal a ...... neck squamous cell carcinoma.
@en
Clinical value of monoclonal a ...... neck squamous cell carcinoma.
@nl
prefLabel
Clinical value of monoclonal a ...... neck squamous cell carcinoma.
@en
Clinical value of monoclonal a ...... neck squamous cell carcinoma.
@nl
P2093
P2860
P921
P1433
P1476
Clinical value of monoclonal a ...... d neck squamous cell carcinoma
@en
P2093
Anna Wegner
Wiktoria Blaszczak
Wojciech Golusinski
P2860
P2888
P356
10.1007/S12032-017-0918-1
P5008
P577
2017-03-17T00:00:00Z